Komori
Alfresa Holdings (2784) · FactFirst stated

FY2019-Q2 Self-Medication Wholesale Business: Higher Revenue, Lower Profit

First written in FY2019-Q2. . Latest entry: FY2019-Q2.

1entries
1years
0from disclosures
Share on X
How it moved
Same theme, other companies
Revenue Growth and Profit Decline in the Self-Medication Wholesale BusinessA theme 1 companies write about · 1 as a headwind · 0 as a tailwind

No other company in this theme has enough history to compare yet.

Full recordFilings, disclosures and news, newest first
  1. FY2019-Q2First statedAnnual report

    「当セグメントの第２四半期連結累計期間の業績は、サプリメント・健康食品および一般用医薬品等の売上増加により、売上高1,373億27百万円（前年同期比2.1％増）、営業利益14億48百万円（同2.9％減）となりました。」

    セルフメディケーション卸売事業は増収となった一方、営業利益は前年同期比2.9％減となった。
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Alfresa Holdings yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.